Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' Equity

v3.21.2
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' Equity - USD ($)
Ordinary Shares [Member]
Class B Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Class B Ordinary Shares [Member]
Beginning balance at Feb. 01, 2021 $ 0 $ 0 $ 0 $ 0  
Beginning balance (in shares) at Feb. 01, 2021 0        
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Issuance of Class B ordinary shares to Sponsor [1],[2] $ 575 24,425 0 25,000  
Issuance of Class B ordinary shares to Sponsor (in shares) 5,750,000 [1],[2]       7,187,000
Net loss $ 0 0 (10,216) (10,216)  
Ending balance at Mar. 31, 2021 $ 575 24,425 (10,216) 14,784  
Ending balance (in shares) at Mar. 31, 2021 5,750,000        
Beginning balance at Feb. 01, 2021 $ 0 0 0 0  
Beginning balance (in shares) at Feb. 01, 2021 0        
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net loss       (10,216)  
Ending balance at Sep. 30, 2021 $ 575 24,425 (10,216) 14,784  
Ending balance (in shares) at Sep. 30, 2021 5,750,000        
Beginning balance at Mar. 31, 2021 $ 575 24,425 (10,216) 14,784  
Beginning balance (in shares) at Mar. 31, 2021 5,750,000        
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net loss $ 0 0 0 0  
Ending balance at Jun. 30, 2021 $ 575 24,425 (10,216) 14,784  
Ending balance (in shares) at Jun. 30, 2021 5,750,000        
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net loss $ 0 0 0 0  
Ending balance at Sep. 30, 2021 $ 575 $ 24,425 $ (10,216) $ 14,784  
Ending balance (in shares) at Sep. 30, 2021 5,750,000        
[1] Includes an aggregate of up to 750,000 shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriter.
[2] Our initial shareholders initially held 7,187,000 Class B ordinary shares, up to 937,500 of which were subject to forfeiture by our sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. On August 20, 2021, the sponsor surrendered for no consideration 1,287,000 Class B ordinary shares of the Company. On September 9, 2021, the sponsor surrendered an additional 150,000 Class B ordinary shares for no consideration. All share and per-share amounts have been retroactively restated to reflect the share capitalization and return of shares.